Skip to main content
Open this photo in gallery:

Bottles of Johnson's baby powder are displayed in a store in New York on Jan. 22, 2019.Brendan McDermid/Reuters

Johnson & Johnson will pay more than US$100-million to settle over 1,000 lawsuits that allege the company’s Baby Powder caused cancer, Bloomberg news reported on Monday, citing people with knowledge of the pacts.

J&J faces more than 19,000 lawsuits from consumers and their survivors claiming its talc products caused cancer owing to contamination with asbestos, a known carcinogen. The company has maintained that its talc is safe.

The drug-maker declined to comment on the Bloomberg report, but reiterated that its talc is safe, does not contain asbestos and does not cause cancer.

“In certain circumstances, we do choose to settle lawsuits, which is done without an admission of liability and in no way changes our position regarding the safety of our products,” the company said in a statement.

In May, J&J said it would stop selling its talc in the United States and Canada after demand had fallen in the wake of what it called “misinformation” about the product’s safety amid a barrage of legal challenges.

J&J has faced scrutiny over the safety of its baby powder following an investigative report by Reuters in 2018 that found the company knew for decades that asbestos lurked in its talc.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Report an editorial error

Report a technical issue

Tickers mentioned in this story

Study and track financial data on any traded entity: click to open the full quote page. Data updated as of 21/11/24 6:40pm EST.

SymbolName% changeLast
JNJ-N
Johnson & Johnson
+1.56%155.5

Follow related authors and topics

Authors and topics you follow will be added to your personal news feed in Following.

Interact with The Globe